Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 36, Issue 4, 2009, Pages 757-759

  Andersen, Trine ^a   Munthe Fog, Lea ^a   Garred, Peter ^a   Jacobsen, Søren ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Complications; Etiology; Ficolin; Human FCN3 protein; Immunology; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; FICOLIN; FICOLIN 3; UNCLASSIFIED DRUG; FCN3 PROTEIN, HUMAN; GLYCOPROTEIN; LECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; COOMBS TEST; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HEMOLYSIS; HUMAN; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GLYCOPROTEINS; HUMANS; LECTINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 66149122619     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080361     Document Type: Article

References (15)

1. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982;25:1271-7.
2. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement defiency, and apoptosis. Adv Immunol 2000;76:227-324.
3. Nauta AJ, Trouw LA, Daha MR, et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002;32:1726-36.
4. Nauta AJ, Raaschou-Jensen N, Roos A, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003;33:2853-63.
5. Sugimoto R, Yae Y, Akaiwa M, et al. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem 1998;273:20721-7.
6. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol 2002;168:3502-6.
7. Honore C, Hummelshoj T, Hansen BE, Madsen HO, Eggleton P, Garred P. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum 2007;56:1598-607.
8. Jacobsen S, Petersen J, Ullman S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998;17:468-77.
9. Petri M, Buyon J, Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999;8:685-91.
10. Munthe-Fog L, Hummelshøj T, Ma YJ, et al. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 2008;45:2660-6.
11. Seelen MA, van der Bijl EA, Trouw LA, et al. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. Rheumatology Oxford 2005;44:111-9.
12. Bijl M, Horst G, Bijzet J, Bootsma H, Limburg PC, Kallenberg CG. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Arthritis Rheum 2003;48:248-54.
13. Bijl M, Bootsma H, Van Der Geld Y, Limburg PC, Kallenberg CG, Van Rijswijk MH. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction. Ann Rheum Dis 2004;63:831-5.
14. Vogt B, Führnrohr B, Müller R, Sheriff A. CRP and the disposal of dying cells: Consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 2007;40:295-8.
15. Yae Y, Inaba S, Sato H, Okochi K, Tokunaga F, Iwanaga S. Isolation and characterization of a thermolabile beta-2 macroglycoprotein ('thermolabile substance' or 'Hakata antigen') detected by precipitating (auto) antibody in sera of patients with systemic lupus erythematosus. Biochim Biophys Acta 1991;1078:369-76.